Mexico Plans Tougher Controls On Medicine Buying

13 October 1996

Because of the growing misuse of medicines by students in Mexico, the Ministry of Health has announced that it is setting up strict controls on the purchase of medicines in general and prescription drugs in particular. Initially these will apply to Mexico City but the controls will be expanded nationwide in due course.

Apart from the problems of drug purchasing without prescription, the Ministry and the Pharmacists Union of the Valley of Mexico (which first brought the MoH's attention to the problem) plan concerted action on sales of drugs to adult consumers. Prescription drug sales in Mexico have never been fully regulated, although packing does indicate which drugs can only be sold with a doctor's prescription.

In many cases, if a prescription was required and none was produced, pharmacists followed the practice of offering a "substitute medicine," having more or less the same formula and strength. Now this practice is to be eliminated, according to medical authorities. The Ministry has said it will put in force increased supervision of medicines, as well as their distribution, and will welcome complaints where violations are observed.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight